Manufacturer record
Eris Lifesciences Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Eris Lifesciences Limited (Assam) were declared Not of Standard Quality between August 2022 and January 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Eris Lifesciences Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP (GlimiSave M2 Tablets) | GGLV22007Mfg 2022-03 · Exp 2025-02 | DissolutionDissolution | RDTL ChandigarhState lab | Jan 2023 |
| Aceclofenac 100 mg & Thiocolchicoside 4 mg Tablets (Zerodol TH 4 Tablets) | FXT011022ASMfg 2021-12 · Exp 2024-11 | Identification and Assay of ThiocolchicosideAssay | RDTL ChandigarhState lab | Jan 2023 |
| Velgut (Prebiotic & Probiotic Capsules) | GVGC22003Mfg 2022-02 · Exp 2023-07 | AssayAssay | CDL KolkataCDSCO lab | Aug 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.